NAFLD (non-alcoholic fatty liver disease) encompasses the spectrum of fatty liver disease in
insulin-resistant individuals who often display T2DM (Type 2 diabetes mellitus) and obesity …

Non-alcoholic fatty liver disease (NAFLD) has emerged as one of the leading liver diseases
worldwide. NAFLD is characterized by hepatic steatosis and may progress to an …

AIMS: To review available data concerning the basic science and epidemiological-clinical
evidence for an association of NAFLD and cardiovascular disease. DATA SYNTHESIS: Non …

The most common cause of death in patients with nonalcoholic fatty liver disease (NAFLD) is
coronary artery disease (CAD), not chronic liver disease. Fatty liver increases cardiovascular …

Objective To provide a comprehensive review summarizing the existing evidence on the
association between nonalcoholic fatty liver disease (NAFLD) and hypertension (HT) …

Context Nonalcoholic fatty liver disease (NAFLD) prevalence is high, especially in patients
with obesity and type 2 diabetes, and is expected to rise steeply in the coming decades …

Non-alcoholic fatty liver disease (NAFLD) encompasses pure steatosis through nonalcoholic
steatohepatitis (NASH) and is the most common cause of chronic liver disease in Western …

Non-Alcoholic Fatty Liver Disease (NAFLD) is caused by the accumulation of fat in over 5%
of hepatocytes in the absence of alcohol consumption. NAFLD is considered the hepatic …

Methods Data from the National Health and Nutrition Examination Survey 1999–2018 was
used. Hepatic steatosis was defined with United States Fatty Liver Index (US-FLI) and FLI at …

Background: Nonalcoholic fatty liver disease (NAFLD) is emerging as a public health issue
worldwide and is highly prevalent in patients with type 2 diabetes mellitus (T2DM). However …